Spatial tumor immune microenvironment analysis of KRAS-mutated Non-Small Cell Lung Cancer and immunotherapy outcome

被引：0
|
作者：
Zhao, Dan
Li, Haiqing
Mambetsariev, Isa
Mirzapoiazova, Tamara
Chen, Chen
Fricke, Jeremy
Wheeler, Deric
Arvanitis, Leonidas
Pillai, Raju
Afkhami, Michelle
Chen, Bihong T.
Sattler, Martin
Erhunmwunsee, Loretta
Massarelli, Erminia
Kulkarni, Prakash
Amini, Arya
Armstrong, Brian
Salgi, Ravi
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-LB_C17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB_C17
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Deciphering the Characterization of Tumor Microenvironment in EGFR-Mutated Non-Small Cell Lung Cancer
    Qiao, M.
    Jiang, T.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S182 - S183
  • [32] Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non-Small Cell Lung Cancer and EGFR- and KRAS-Mutated Tumors
    Li, Meijuan
    Yang, Lei
    Hughes, Jason
    van den Hout, Allison
    Burns, Christine
    Woodhouse, Ryan
    Dennis, Lucas
    Hegde, Priti
    Oxnard, Geoffery R.
    Vietz, Christine
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (05): : 543 - 553
  • [33] The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer
    Zhu, Dao Qi
    Liu, Ying
    Yu, Zhi Jian
    Zhang, Ru Hua
    Li, Ai Wu
    Gong, Feng Ying
    Wang, Wei
    Xiao, Wei
    Fan, Qin
    WORLD JOURNAL OF ONCOLOGY, 2022, 13 (02) : 84 - 95
  • [34] Investigating digital pathology tumor microenvironment features for immunotherapy outcome in patients with advanced non-small cell lung cancer
    Ebot, Ericka M.
    Chen, Kuei-Ting
    Biggs, Mikayla
    Lin, Douglas I.
    Elvin, Julia A.
    Frampton, Garrett M.
    Pao, James J.
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
    Ye, Wei
    Li, Meiye
    Luo, Kewang
    PHARMACEUTICS, 2023, 15 (07)
  • [36] The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer
    Lee, Ming-Ching
    Buitrago, Daniel H.
    Kadota, Kyuichi
    Ujiie, Hideki
    Woo, Kaitlin
    Sima, Camelia S.
    Travis, William D.
    Jones, David R.
    Adusumilli, Prasad S.
    ONCOIMMUNOLOGY, 2014, 3 (11): : e967142 - 1
  • [37] Combined inhibition of MEK and p38 efficiently inhibits cell growth of KRAS-mutated non-small cell lung cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Tsukagoshi, Yusuke
    Kasahara, Norimitsu
    Sakurai, Reiko
    Kaira, Kyoichi
    Hisada, Takeshi
    CANCER SCIENCE, 2018, 109 : 587 - 587
  • [38] Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence
    Zhao, Jiaping
    Lu, Yu
    Wang, Zhaofeng
    Wang, Haiying
    Zhang, Ding
    Cai, Jinping
    Zhang, Bei
    Zhang, Junling
    Huang, Mengli
    Pircher, Andreas
    Patel, Krishna H.
    Ke, Honggang
    Song, Yong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (09)
  • [39] Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis
    Aptekar, Jacob
    Jain, Rahul
    Korytowsky, Beata
    Shafquat, Afrah
    Hendershot, Jacob
    Talwai, Aniketh
    Itzkovich, Yahav
    Padda, Sukhmani K.
    LUNG CANCER, 2024, 193
  • [40] Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
    Abascal, Jensen
    Oh, Michael S.
    Liclican, Elvira L.
    Dubinett, Steven M.
    Salehi-Rad, Ramin
    Liu, Bin
    CELLS, 2023, 12 (19)
12345